drugset / Trial / NCT01395108

Clinical Study on Oral Nemonoxacin Malate Capsules

NCT01395108

Phase 1 Completed 76 enrolled TaiGen Biotechnology Co., Ltd.
RandomizedSingle-groupQuadruple-blindTreatment

Summary

The purpose of this study is to evaluate the safety and tolerability of nemonoxacin in healthy Chinese volunteers.

Timeline

Start
2008-01
Primary completion
2008-08
Completion
2008-08

Drugs

EvaluationDrugModalityDoseRoute
Comparator Nemonoxacin Small molecule 125 mg Oral
Comparator Nemonoxacin Small molecule 250 mg Oral
Comparator Nemonoxacin Small molecule 500 mg Oral
Comparator Nemonoxacin Small molecule 750 mg Oral
Comparator Nemonoxacin Small molecule 1000 mg Oral

Indications

No indication recorded.